Investing in Growth, Enabling Change
English      中文

Arsenal Capital Partners is a progressive private equity firm that
facilitates transformational growth and change through a
collaborative approach.


Elite Comfort Solutions Appoints Chris Chrisafides as Chief Executive Officer

NEWNAN, GA January 9, 2017 - Elite Comfort Solutions LLC (ECS) today announced that the board of directors has selected Chris Chrisafides as its Chief Executive Officer.

Chrisafides most recently led Dow Chemical’s North American $1.0+ billion polyurethane division as the Commercial Vice President.  Prior to that he served in a variety of senior leadership roles, including General Manager and Global Business Development Director at Rohm & Haas.


TractManager Appoints Trace Devanny Chief Executive Officer

Accomplished Industry Leader and Former Nuance Communications, TriZetto and Cerner Executive to Champion Exceptional Customer Engagement and Product Innovation

CHATANOOGA, Tenn. & DALLAS, October 27, 2016 - TractManager, the leading provider of powerful healthcare strategic sourcing and compliance application suites announced that it has named Trace Devanny Chief Executive Officer of the company. Devanny will advance the continuing growth of the knowledge based and system solutions TractManager supplies to over 3,000 hospital and provider clients.

“Trace blends a remarkable...

Arsenal Capital Partners Hires Spaight as Healthcare Operating Partner

Spaight Previously Served as Chairman and Chief Executive Officer of WIL Research Company, Inc.

NEW YORK, October 17, 2016 — Arsenal Capital Partners, a leading New York based private equity firm that invests in middle market healthcare and specialty industrial companies, announced today that it has expanded its team with the addition of David Spaight. Mr. Spaight will work as an Operating Partner within the firm’s Healthcare Group.

Mr. Spaight was most recently Chairman and Chief Executive Officer of WIL Research Company, where he led the successful turnaround of...

Arsenal Capital Partners Closes Fund IV at $1.3 Billion Hard Cap

Leading Sector-Focused Firm Specializing in Strategic Buy and Builds

NEW YORK, October 13, 2016 – Arsenal Capital Partners (“Arsenal”), a leading New York-based private equity firm that invests in lower middle market specialty industrial and healthcare companies, announced today that it has successfully completed fundraising for Arsenal Capital Fund IV LP (“Fund IV”) at its $1.3 billion hard cap.  The firm’s previous fund, Arsenal Capital Partners III LP, was raised in 2012 with $875 million of committed capital....

American Securities to Acquire Chromaflo Technologies from Arsenal Capital Partners and Nordic Capital

New York, NY, October 5, 2016 – American Securities LLC, Arsenal Capital Partners, and Nordic Capital Fund VI today announced that American Securities has partnered with management and signed a definitive agreement to acquire Chromaflo Technologies Corp. (“Chromaflo” or the “Company”), a leading producer of proprietary, high-performance colorants and chemical dispersions, from Arsenal Capital Partners and Nordic Capital. The transaction is expected to close in...

Arsenal Capital Partners Completes Sale Of Kel-Tech Inc. To Clariant

NEW YORK, October 3, 2016 - Arsenal Capital Partners (“Arsenal”) announced today that it has completed the sale of its portfolio company Kel-Tech Inc. ("Kel-Tech" or the "Company"), a manufacturer and supplier of specialty chemical products and services for onshore production, field stimulation, and drilling applications throughout the United States, to Clariant Corporation (“Clariant”).  Financial terms of the transaction were not...

Mouse over text to stop rotation
Copyright © 2005 - 2017 Arsenal Capital Partners. All rights reserved.